D7. D007 ADVANCES IN ASTHMA THERAPIES

Oral Corticosteroid-Sparing Effect of Tezepelumab in Adults with Severe Asthma

Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1197 M. Wechsler, A. Menzies Gow, C. Brightling, P. Kuna, S. Korn, T. Welte, J. Griffiths, K. Sałapa, Hellqvist, G. Almqvist, P. Kaur, T. Skärby, G. Colice

Phase III Evaluation of the Efficacy and Safety of PT027 (Budesonide/Albuterol pMDI) Compared to Placebo pMDI on Exercise-Induced Bronchoconstriction in Adult and Adolescent Subjects with Asthma: the TYREE Study

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1200 C. Laforce, B. Chipps, F. Albers, L. Reilly, E. Johnsson, H. Andrews, C. Cappelletti, A. Maes, A. Papi

Long-Term Dupilumab Treatment in Moderate-to-Severe Asthma with Type 2 Inflammation: Open Label LIBERTY ASTHMA TRAVERSE Study

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1201 M. Wechsler, I. Pavord, A. Papi, K. Chapman, X. Mao, B. Ortiz, M. Djandji, M. K. Ruddy, E. Laws, N. Amin, D. Lederer, M. Hardin